Literature DB >> 25331017

Self-folded redox/acid dual-responsive nanocarriers for anticancer drug delivery.

Yue Lu1, Ran Mo, Wanyi Tai, Wujin Sun, Dennis B Pacardo, Chenggen Qian, Qundong Shen, Frances S Ligler, Zhen Gu.   

Abstract

Self-folded redox/acid dual-responsive nanocarriers (RAD-NCs) are developed for physiologically triggered delivery of anticancer drugs. The evidenced redox/acid responsiveness, facile decoration of ligands, and active tumor-targeting capability of RAD-NCs suggest their potential as a promising formulation for tumor-targeted chemotherapy.

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25331017      PMCID： PMC4425410          DOI： 10.1039/c4cc07004f

Source DB:  PubMed          Journal:  Chem Commun (Camb)        ISSN： 1359-7345            Impact factor:   6.222


  45 in total

Review 1.  Reduction-sensitive polymers and bioconjugates for biomedical applications.

Authors:  Fenghua Meng; Wim E Hennink; Zhiyuan Zhong
Journal:  Biomaterials       Date:  2009-02-05       Impact factor: 12.479

2.  pH-sensitive vesicles based on a biocompatible zwitterionic diblock copolymer.

Authors:  Jianzhong Du; Yiqing Tang; Andrew L Lewis; Steven P Armes
Journal:  J Am Chem Soc       Date:  2005-12-28       Impact factor: 15.419

Review 3.  Mesoporous silica nanoparticles as controlled release drug delivery and gene transfection carriers.

Authors:  Igor I Slowing; Juan L Vivero-Escoto; Chia-Wen Wu; Victor S-Y Lin
Journal:  Adv Drug Deliv Rev       Date:  2008-04-10       Impact factor: 15.470

4.  Triggered Nanoparticles as Therapeutics.

Authors:  Chang Soo Kim; Bradley Duncan; Brian Creran; Vincent M Rotello
Journal:  Nano Today       Date:  2013-08-01       Impact factor: 20.722

5.  A novel rapamycin-polymer conjugate based on a new poly(ethylene glycol) multiblock copolymer.

Authors:  Wanyi Tai; Zhijin Chen; Ashutosh Barve; Zhonghua Peng; Kun Cheng
Journal:  Pharm Res       Date:  2013-09-26       Impact factor: 4.200

Review 6.  Targeted therapies for cancer 2004.

Authors:  Jeffrey S Ross; David P Schenkein; Robert Pietrusko; Mark Rolfe; Gerald P Linette; James Stec; Nancy E Stagliano; Geoffrey S Ginsburg; W Fraser Symmans; Lajos Pusztai; Gabriel N Hortobagyi
Journal:  Am J Clin Pathol       Date:  2004-10       Impact factor: 2.493

7.  Disulfide cross-linked polyurethane micelles as a reduction-triggered drug delivery system for cancer therapy.

Authors:  Shuangjiang Yu; Jianxun Ding; Chaoliang He; Yue Cao; Weiguo Xu; Xuesi Chen
Journal:  Adv Healthc Mater       Date:  2013-10-31       Impact factor: 9.933

Review 8.  Nanocarriers as an emerging platform for cancer therapy.

Authors:  Dan Peer; Jeffrey M Karp; Seungpyo Hong; Omid C Farokhzad; Rimona Margalit; Robert Langer
Journal:  Nat Nanotechnol       Date:  2007-12       Impact factor: 39.213

Review 9.  Emerging micro- and nanotechnology based synthetic approaches for insulin delivery.

Authors:  Ran Mo; Tianyue Jiang; Jin Di; Wanyi Tai; Zhen Gu
Journal:  Chem Soc Rev       Date:  2014-03-14       Impact factor: 54.564

Review 10.  Nanoparticle therapeutics: an emerging treatment modality for cancer.

Authors:  Mark E Davis; Zhuo Georgia Chen; Dong M Shin
Journal:  Nat Rev Drug Discov       Date:  2008-09       Impact factor: 84.694
View more
  2 in total

1.  ATP-Responsive Drug Delivery Systems.

Authors:  Wujin Sun; Zhen Gu
Journal:  Expert Opin Drug Deliv       Date:  2016-02-01       Impact factor: 6.648

Review 2.  Smart micro/nanoparticles in stimulus-responsive drug/gene delivery systems.

Authors:  Mahdi Karimi; Amir Ghasemi; Parham Sahandi Zangabad; Reza Rahighi; S Masoud Moosavi Basri; H Mirshekari; M Amiri; Z Shafaei Pishabad; A Aslani; M Bozorgomid; D Ghosh; A Beyzavi; A Vaseghi; A R Aref; L Haghani; S Bahrami; Michael R Hamblin
Journal:  Chem Soc Rev       Date:  2016-03-07       Impact factor: 54.564
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.